FindTrial
Sign In

COMPARING OUTCOME OF SALBUTAMOL (BRONCHODILATOR) ADMINISTRATION THROUGH METERED DOSE INHALER (PUFF) AND NEBULISER DURING ASTHMA EMERGENCIES

COMPARISON OF EFFICACY OF NEBULISER AND METERED DOSE INHALER(MDI) WITH SPACER FOR THE ADMINISTRATION OF AEROSOLISED SALBUTAMOL IN THE TREATMENT OF ACUTE EXACERBATION OF ASTHMA IN CHILDREN

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/01/039093
Enrollment
66
Registered
2022-01-03
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J453- Mild persistent asthma

Interventions

Intervention1: Aerosolised salbutamol administered through nebuliser and Metered dose inhaler: comparison of efficacy of salbutamol administered with nebuliser and metered dose inhaler Intervention2:

Sponsors

M LENAA SAKTHIYAVATHY
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: children aged 6 years to 12 years presenting with acute exacerbation of asthma with past history of acute exacerbation of asthma

Exclusion criteria

Exclusion criteria: CHILDREN LESS THAN 6 YEARS DUE TO DIFFICULTY PERFOMING PEFR CHILDREN WITH HYPOXEMIA SpO2 LESS THAN 90% ROOM AIR CHILDREN WITH CLINICAL SEVERITY SCORE 12-15 (SEVERE) CHILDREN WITH CLINICAL OR RADIOLOGICAL EVIDENCE OF PNEUMONIA

Design outcomes

Primary

MeasureTime frame
compare the efficacy of aerosolised salbutamol administered with nebuliser and MDI with spacer in the treatment of acute asthma in childrenTimepoint: 40 minutes—

Secondary

MeasureTime frame
to measure outcome based on oxygen saturation, Clinical severity score, PEFRTimepoint: 40 minutes—

Countries

India

Contacts

Public ContactDR K KUPPUSAMY

SRI MANAKULA VINAYAGAR MEDICAL COLLEGE HOSPITAL, KALITHEERTHALKUPPAM, PONDICHERRY

drkuppusamyk@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026